-
Dabrafenib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Dabrafenib -
Aprocitetan
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Aprocitetan -
Etrasimod
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Etrasimod Isilonda sesilonda esiswini (UC) Arena(Pfizer) Mar.05,2030 -
Tirzepatide
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Tirzepatide Uhlobo lwe-2 yeswekile, ukunciphisa umzimba Eli Lilly Jan.05,2036 -
Semaglutide
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Semaglutide Type2 seswekile, ukunciphisa umzimba Novo Nordisk Dec.05,2031 -
Oteseconazole
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Oteseconazole Ukunciphisa izinga lezehlo ze i-candidiasis ye-vulvovaginal ephindaphindiweyo
MycoviaPharmaceuticals Epreli.22,2031 -
Finerenone
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Finerenone Isifo seswekile seNephropathy Bayer Epreli.12,2029 -
Vibegron
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Vibegron OAB Urovant Dec.01,2030 -
I-Caivasertib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Caivasertib umhlaza webele AstraZeneca Matshi 10.2030 -
I-Resmetirom
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Resmetirom NASH Roche Sep.12,2026 -
I-Darolutamide
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) I-Darolutamide unyango lomhlaza wedlala lesinyi Bayer Matshi 25,2033 -
Upadacitinib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Upadacitinib I-Atopic Dermatitis ABBVIE INC Dec.01,2030